{
    "Orphapacket": {
        "ORPHApacketId": "369913",
        "creationDate": "2023-06-22 11:33:23",
        "version": "1.3.25 / 4.1.7 [2023-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "369913",
        "Label": "Combined oxidative phosphorylation defect type 17",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_369913",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "COXPD17"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "615440",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Combined oxidative phosphorylation defect type 17 is a rare genetic mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by infantile-onset of severe hypertrophic cardiomyopathy (that occasionally progresses to dilated cardiomyopathy) associated with failure to thrive global development delay muscular hypotonia elevated serum lactate and complex I deficiency in skeletal muscle biopsy. Intellectual disability pericardial effusion and a mild cardiac phenotype have been also reported."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "ELAC2",
                    "Name": "elaC ribonuclease Z 2",
                    "ExternalReferences": [],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "35696",
                        "Label": "Mitochondrial disorder due to a defect in mitochondrial protein synthesis"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "217587",
                        "Label": "Mitochondrial disease with hypertrophic cardiomyopathy"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "23849775[PMID]_27769300[PMID]_28441660[PMID]",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Family",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET_27769300[PMID]_28441660[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Infancy"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Neonatal"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}